Stories written by

Maureen Ferran, The Conversation

Already approved in India, a new patent-free Covid-19 vaccine could be a game changer globally

CORBEVAX is anticipated to significantly expand vaccine access to people in low- and middle-income countries.

Maureen Ferran, The Conversation
· Jan 21, 2022 · 01:30 pm
How is the Johnson & Johnson vaccine different from the others? A virologist explains

It is the difference that could make it a huge help to global vaccination efforts.

Maureen Ferran, The Conversation
· Mar 02, 2021 · 11:30 pm